Dual Immune Checkpoint Inhibition in Melanoma and PD-L1 Expression: The Jury Is Still Out Clinical trials frequently include multiple end points that mature at different times. The initial report, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results